ACM
ELV icon

Alcosta Capital Management’s Elevance Health ELV Stock Holding History

Alcosta Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,569
Closed -$3.02M – 34
2023
Q1 		$3.02M Sell
6,569
-184
-3% -$87.6K 2.89% 17
2022
Q4 		$3.46M Sell
6,753
-223
-3% -$113K 3.49% 10
2022
Q3 		$3.17M Sell
6,976
-194
-3% -$92.8K 3.11% 15
2022
Q2 		$3.46M Sell
7,170
-4
-0.1% -$1.98K 3.29% 13
2022
Q1 		$3.52M Buy
+7,174
New +$3.28M 2.53% 24

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Alcosta Capital Management's ELV Position: Q2 2023 in Review

Alcosta Capital Management sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 6,569 shares — an estimated $3.02M sold.

Alcosta Capital Management first reported a position in ELV in Q1 2022 and held it in 5 quarters. The position peaked at $3.52M in Q1 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Alcosta Capital Management reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Alcosta Capital Management sold 6,569 Elevance Health shares in Q2 2023, an estimated $3.02M.
  • Alcosta Capital Management first reported a position in Elevance Health in Q1 2022 and held it in 5 quarters.
  • Alcosta Capital Management's Elevance Health position peaked at $3.52M in Q1 2022.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Alcosta Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.